A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

So how the treatment changed depending on grade is really, if we look at the IDH mutated patient, right? So, there is grade 2, 3 and 4 and now for grade 2 patients, really the treatment is ...